16
NPS Score
VS
bluebird bio
- EMPLOYEE
PARTICIPANTS - 7
- TOTAL
RATINGS
Intellia Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 12
- TOTAL
RATINGS
bluebird bio vs Intellia Therapeutics
Compare bluebird bio versus Intellia Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 7 employees and customers of bluebird bio and 12 employees and customers of Intellia Therapeutics.
bluebird bio
bluebird bio's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of bluebird bio. Their current market cap is $410.75M.
Intellia Therapeutics
Intellia Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intellia Therapeutics. Their current market cap is $5.42B.
4.2/5
Product Quality
3.5/5
4/5
Pricing
3.3/5
3.9/5
Customer Service
3.9/5
| 33% | Promoters |
|---|---|
| 50% | Passive |
| 17% | Detractors |
49
NPS Score
| 66% | Promoters |
|---|---|
| 17% | Passive |
| 17% | Detractors |
Net Promoter Score
Winner by 33
See how bluebird bio compares to its competitors
Working at bluebird bio vs Working at Intellia Therapeutics
49 / 100
CEO Rating
86 / 100
CEO Rating
Winner by 37%
bluebird bio
bluebird bio doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Intellia Therapeutics
Employees at Intellia Therapeutics rate their CEO, John Leonard, 86/100. This score is 37% higher than the scores of bluebird bio's CEO, Nick Leschly.